<DOC>
	<DOC>NCT03094494</DOC>
	<brief_summary>An observational two-center case-control study exploring the clinical impact of double-carbapenem use in a population of critically il patients with severe carbapenem-resistant Klebsiella pneumoniae infection</brief_summary>
	<brief_title>Double Carbapenem as Rescue Strategy for the Treatment of Carbapenemase-Producing Klebsiella Pneumoniae Infections</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Klebsiella Infections</mesh_term>
	<criteria>1. age ≥ 18 years; 2. ICU admission between November 2012 and December 2015; 3. documented CRKp invasive infection; 4. targeted antibiotic therapy lasting ≥ 72 hours Exclusion Criteria 1. Klebsiella infection, susceptible to carbapenems 2. Duration of antimicrobial therapy less than 72 hours 3. Data not completely available from the electronically medical chart</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>